drugset / Trial / NCT00020904

BMS-247550 in Treating Women With Metastatic Breast Cancer

NCT00020904

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating women who have stage IV or recurrent metastatic breast cancer.

Timeline

Start
2001-02
Primary completion
2003-01
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous

Indications